Catching a Killer - New Steps
Taken in Treating Mesothelioma
By: Maggie Kay
There’s a silent killer out there. It creeps up on its
victims, attacks them quietly and unsuspectingly, and initiates
a wound that develops over many years before it eventually
causes pain. This unstoppable murderer is known as
mesothelioma.
Mesothelioma is a malignant tumor that develops on the
mesothelial cells of either the lungs, heart or abdominal
organs, and plagues those who have been exposed to asbestos for
a prolonged period of time. Many who fall victim to this
disease are people who have worked in specific trades or fields
prior to the 1970s, such as blacksmiths, electricians,
millwrights, and oil refinery workers.
Since it can take up to forty years for symptoms to surface,
mesothelioma-related deaths are higher than ever in the 21st
century. The Centers for Disease Control and Prevention state
that 1,493 people died from asbestos in 2000, compared to 77
people in 1968.
Mesothelioma treatment methods differ depending on the stage
of the cancer upon detection, as well as the patient’s age and
personal choice of treatment. The four distinct stages of the
disease are a factor in determining the type of mesothelioma
treatment that can be carried out. The first stage is when the
tumor has had limited growth on the pleural lining (the lining
of the lungs). At this stage, an attempt can be made to
surgically remove the entire tumor. However, if the tumor is
detected at a later stage when it has invaded surrounding
areas, it is considered incurable.
Traditionally, the later stages of mesothelioma have been
treated with either chemotherapy or radiation therapy.
Chemotherapy uses drugs to kill cancer cells while radiation
therapy uses high-energy x-rays to kill cancer cells and shrink
tumors.
Although mesothelioma treatment methods have been proven to
prolong patients’ lives, they cannot cure the disease. Ongoing
clinical trials are dedicated to overcoming this debilitating
illness. Current experimental treatments include the
following:
Drug Therapy: A drug called Alimta, developed by Eli Lilly,
has been shown to significantly increase the life expectancy of
patients and decrease symptoms of the disease. It is the only
chemotherapy drug to be approved by the Food and Drug
Administration for the treatment of patients with malignant
pleural mesothelioma.
Gene Therapy: This mesothelioma treatment is currently in
the experimental stages. The process involves inserting a
"suicide gene" directly into the tumor. This gene makes the
cells sensitive to a normally ineffective drug called
glanciclovir which destroys all the cancer cells and leaves the
healthy cells unharmed.
Photodynamic Therapy: Still in its experimental stage,
photodynamic therapy uses light to kill cancerous cells. The
patient first receives a photosensitizer that only collects in
cancerous cells. Fiberoptic cables are then placed in the body
in order to focus the right frequency of light on the tumor.
The photosensitizer is then caused to produce a toxic oxygen
molecule that kills the cancer cell.
Immunotherapy: Also referred to as biological therapy, this
mesothelioma treatment uses the body's personal immune system
to defend itself against mesothelioma. It has been discovered
that the immune system is capable of deciphering healthy cells
from cancerous cells, and can thus eradicate those cells that
cause cancer.
While treatment methods are still in the developmental or
experimental stages, there is hope that one day all
mesothelioma victims will be freed from the murderous hands of
this fearsome disease.
|